0001790478-20-000002.txt : 20200320 0001790478-20-000002.hdr.sgml : 20200320 20200320171640 ACCESSION NUMBER: 0001790478-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 EFFECTIVENESS DATE: 20200320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CerSci Therapeutics Inc. CENTRAL INDEX KEY: 0001790478 IRS NUMBER: 473216301 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-350547 FILM NUMBER: 20732857 BUSINESS ADDRESS: STREET 1: 17217 WATERVIEW PARKWAY SUITE 1.202 CITY: DALLAS STATE: TX ZIP: 75252 BUSINESS PHONE: 2143066218 MAIL ADDRESS: STREET 1: 17217 WATERVIEW PARKWAY SUITE 1.202 CITY: DALLAS STATE: TX ZIP: 75252 D/A 1 primary_doc.xml X0708 D/A LIVE 0001790478 CerSci Therapeutics Inc. 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 2143066218 DELAWARE None None Corporation true 2019 Lucas Rodriguez 17217 Waterview Parkway Suite 1.202 Dallas TX TEXAS 75252 Executive Officer Director Tyler Brous 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director Scott Dax 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director David Genecov 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director David Hitt II 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director Dennis Robbins 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director Pat Confalone 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director Brent Duncan 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director John D. Harkey, Jr. 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director Perry Molinoff 17217 WATERVIEW PARKWAY SUITE 1.202 DALLAS TX TEXAS 75252 Director Pharmaceuticals Decline to Disclose 06b true 0001790478-19-000001 2019-04-04 false true true true true false 0 12000000 11999995 5 false 24 0 0 0 false CerSci Therapeutics Inc. /s/Lucas Rodriguez Lucas Rodriguez Chief Executive Officer 2020-03-18